NCT00191659View on ClinicalTrials.gov

Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents

PHASE3CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

June 30, 2004

Study Completion Date

April 30, 2006

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Atomoxetine Hydrochloride

Trial Locations (1)

RG24 9NL

For additional information regarding investigative sites for this trial, please call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559), Mon - Fri 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Basingstoke

All Listed Sponsors

lead

Eli Lilly and Company

INDUSTRY

NCT00191659 - Study of Broader Efficacy of Atomoxetine in the Treatment of ADHD in Children/Adolescents | Biotech Hunter | Biotech Hunter